Proteomic profiling and potential cellular target identification of K11777, a clinical cysteine protease inhibitor, in Trypanosoma brucei

Chem Commun (Camb). 2012 Jan 21;48(6):835-7. doi: 10.1039/c1cc16178d. Epub 2011 Nov 28.

Abstract

We report herein the design, synthesis and application of K11777-derived activity-based probes (ABPs) allowing in situ profiling and identification of potential cellular targets of K11777 in Trypanosoma brucei.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiparasitic Agents / pharmacology*
  • Cysteine Proteinase Inhibitors / pharmacology*
  • Dipeptides / pharmacology*
  • Gene Expression Profiling
  • Phenylalanine / analogs & derivatives
  • Piperazines
  • Proteomics
  • Protozoan Proteins / metabolism*
  • Tosyl Compounds
  • Trypanosoma brucei brucei / drug effects*
  • Trypanosoma brucei brucei / metabolism
  • Vinyl Compounds / pharmacology*

Substances

  • Antiparasitic Agents
  • Cysteine Proteinase Inhibitors
  • Dipeptides
  • Piperazines
  • Protozoan Proteins
  • Tosyl Compounds
  • Vinyl Compounds
  • N-pip-phenylalanine-homophenylalanine-vinyl sulfone phenyl
  • Phenylalanine